Leveraging publicly available coronavirus data to identify new therapeutic targets for COVID-19.
Many important questions remain regarding severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the viral pathogen responsible for COVID-19. These questions include the mechanisms explaining the high percentage of asymptomatic but highly infectious individuals, the wide variability in diseas...
Guardado en:
Autores principales: | Stacy L Sell, Donald S Prough, Harris A Weisz, Steve G Widen, Helen L Hellmich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b4ec04386c941bd88ccab2052e186c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Traumatic brain injury-induced dysregulation of the circadian clock.
por: Deborah R Boone, et al.
Publicado: (2012) -
Leveraging machine learning essentiality predictions and chemogenomic interactions to identify antifungal targets
por: Ci Fu, et al.
Publicado: (2021) -
Identifying therapeutic targets for schizophrenia
por: Karli Montague-Cardoso
Publicado: (2021) -
Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements
por: Leila Pirhaji, et al.
Publicado: (2017) -
Leveraging non-targeted metabolite profiling via statistical genomics.
por: Miaoqing Shen, et al.
Publicado: (2013)